Overview

How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The study is aimed at Type 2 Diabetics who are taking Metformin, but whose Diabetes remains poorly controlled. There are two additional medications already in use, Glimepiride and Sitagliptin will be compared to assess levels of improvement in Diabetes control.
Phase:
N/A
Details
Lead Sponsor:
The Royal Bournemouth Hospital
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Glimepiride
Glucagon-Like Peptide 1
Sitagliptin Phosphate